Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 IN PLASTIC CONTAINER versus NORMOSOL M AND DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 IN PLASTIC CONTAINER versus NORMOSOL M AND DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 5% IN PLASTIC CONTAINER vs NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides a source of calories and fluid for parenteral nutrition. It increases blood glucose levels and is metabolized to carbon dioxide and water, providing energy. It also serves as a source of water for hydration.
Normosol-M and Dextrose 5% is a balanced electrolyte solution with dextrose. It provides free water, electrolytes, and a source of calories. The dextrose is metabolized to carbon dioxide and water, producing energy. The electrolytes help maintain or restore extracellular fluid balance.
Intravenous infusion: 500-1000 mL as needed based on fluid and caloric requirements. Typical rate: 100-200 mL/hour for maintenance. Maximum infusion rate: 0.5-0.8 g/kg/hour.
Intravenous infusion; dose determined by fluid and electrolyte needs; typical adult rate: 100-200 mL/hour; maximum rate dependent on clinical condition.
None Documented
None Documented
Intravenous: 1.5-2.5 hours for glucose clearance; prolonged in renal impairment or diabetes mellitus
Not applicable; components are endogenous substances with rapid clearance; dextrose half-life ~15-30 min in normal glucose metabolism.
Renal: negligible as unchanged drug; metabolized to water and carbon dioxide, excreted via lungs (>90%) and urine (glucose normally <0.1%)
Renal: Electrolytes and dextrose are excreted renally; dextrose is metabolized to CO2 and water, with no significant fecal or biliary elimination.
Category C
Category C
Intravenous Fluid
Intravenous Fluid